{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:35:24Z","timestamp":1740123324079,"version":"3.37.3"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA058420","CA164974","CA151135"],"award-info":[{"award-number":["CA058420","CA164974","CA151135"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["SAC180086","GTDR15333918","GTDR15333918"],"award-info":[{"award-number":["SAC180086","GTDR15333918","GTDR15333918"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM00844826"],"award-info":[{"award-number":["T32 GM00844826"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["CRP-17-112-06-COUN"],"award-info":[{"award-number":["CRP-17-112-06-COUN"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10549-022-06606-3","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T04:45:00Z","timestamp":1651121100000},"page":"127-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hypertensive diseases of pregnancy and risk of breast cancer in the Black Women\u2019s Health Study"],"prefix":"10.1007","volume":"194","author":[{"given":"Zahna","family":"Bigham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M.","family":"Freund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie R.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4565-7618","authenticated-orcid":false,"given":"Kimberly A.","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"6606_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/jmwh.12725","volume":"63","author":"DM Folk","year":"2018","unstructured":"Folk DM (2018) Hypertensive disorders of pregnancy: overview and current recommendations. J Midwifery & Women\u2019s Health 63:289\u2013300. https:\/\/doi.org\/10.1111\/jmwh.12725","journal-title":"J Midwifery & Women\u2019s Health"},{"key":"6606_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/hr.2016.126","volume":"40","author":"M Umesawa","year":"2017","unstructured":"Umesawa M, Kobashi G (2017) Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res 40:213\u2013220. https:\/\/doi.org\/10.1038\/hr.2016.126","journal-title":"Hypertens Res"},{"key":"6606_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.18741","volume":"3","author":"AJ Butwick","year":"2020","unstructured":"Butwick AJ, Druzin ML, Shaw GM, Guo N (2020) Evaluation of US state-level variation in hypertensive disorders of pregnancy. JAMA Netw Open 3:e2018741. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.18741","journal-title":"JAMA Netw Open"},{"key":"6606_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.3808","volume":"4","author":"NA Bello","year":"2021","unstructured":"Bello NA, Zhou H, Cheetham TC et al (2021) Prevalence of hypertension among pregnant women when using the 2017 American college of cardiology\/American heart association blood pressure guidelines and association with maternal and fetal outcomes. JAMA Netw Open 4:e213808. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.3808","journal-title":"JAMA Netw Open"},{"key":"6606_CR5","unstructured":"Fingar K, Mabry-Hernandez I, Ngo-Metzger Q, et al (2017) Delivery Hospitalizations Involving Preeclampsia and Eclampsia, 2005\u20132014. HCUP Statistical Brief. Agency for Healthcare Research and Quality, Rockville, MD"},{"key":"6606_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21320","volume":"66","author":"CE DeSantis","year":"2016","unstructured":"DeSantis CE, Fedewa SA, Goding Sauer A et al (2016) Breast cancer statistics, 2015 Convergence of incidence rates between black and white women: Breast Cancer Statistics 2015. CA A Cancer J Clinicians 66:31\u201342. https:\/\/doi.org\/10.3322\/caac.21320","journal-title":"CA A Cancer J Clinicians"},{"key":"6606_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583@10.1002\/(ISSN)1097-0142.breastcancercollection","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM et al (2019) Breast cancer statistics 2019. CA A Cancer J Clinicians 69:438\u2013451. https:\/\/doi.org\/10.3322\/caac.21583@10.1002\/(ISSN)1097-0142.breastcancercollection","journal-title":"CA A Cancer J Clinicians"},{"key":"6606_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018: Cancer Statistics. CA Cancer J Clin 68:7\u201330. https:\/\/doi.org\/10.3322\/caac.21442","journal-title":"CA Cancer J Clin"},{"key":"6606_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/jnci\/djy162","volume":"111","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Jemal A (2019) Re: black\u2013white breast cancer incidence trends: effects of ethnicity. J Nat Cancer Instit 111:99\u2013100. https:\/\/doi.org\/10.1093\/jnci\/djy162","journal-title":"J Nat Cancer Instit"},{"key":"6606_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/dme.12796","volume":"33","author":"SAD Bejaimal","year":"2016","unstructured":"Bejaimal SAD, Wu CF, Lowe J et al (2016) Short-term risk of cancer among women with previous gestational diabetes: a population-based study. Diabet Med 33:39\u201346. https:\/\/doi.org\/10.1111\/dme.12796","journal-title":"Diabet Med"},{"key":"6606_CR11","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s10552-013-0242-9","volume":"24","author":"TM Brasky","year":"2013","unstructured":"Brasky TM, Li Y, Jaworowicz DJ et al (2013) Pregnancy-related characteristics and breast cancer risk. Cancer Causes Control 24:1675\u20131685. https:\/\/doi.org\/10.1007\/s10552-013-0242-9","journal-title":"Cancer Causes Control"},{"key":"6606_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ijc.20402","volume":"112","author":"KE Innes","year":"2004","unstructured":"Innes KE, Byers TE (2004) First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 112:306\u2013311. https:\/\/doi.org\/10.1002\/ijc.20402","journal-title":"Int J Cancer"},{"key":"6606_CR13","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3109\/0284186X.2012.750033","volume":"52","author":"JS Kim","year":"2013","unstructured":"Kim JS, Kang EJ, Woo OH et al (2013) The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: a meta-analysis. Acta Oncol 52:1643\u20131648. https:\/\/doi.org\/10.3109\/0284186X.2012.750033","journal-title":"Acta Oncol"},{"key":"6606_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ijc.30065","volume":"139","author":"I Behrens","year":"2016","unstructured":"Behrens I, Basit S, Jensen A et al (2016) Hypertensive disorders of pregnancy and subsequent risk of solid cancer-A nationwide cohort study: Hypertensive disorders of pregnancy and solid cancer. Int J Cancer 139:58\u201364. https:\/\/doi.org\/10.1002\/ijc.30065","journal-title":"Int J Cancer"},{"key":"6606_CR15","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1001\/jama.294.19.2474","volume":"294","author":"S Cnattingius","year":"2005","unstructured":"Cnattingius S (2005) Pregnancy characteristics and maternal risk of breast cancer. JAMA 294:2474. https:\/\/doi.org\/10.1001\/jama.294.19.2474","journal-title":"JAMA"},{"key":"6606_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1158\/1055-9965.EPI-12-1375","volume":"22","author":"R Troisi","year":"2013","unstructured":"Troisi R, Doody DR, Mueller BA (2013) A linked-registry study of gestational factors and subsequent breast cancer risk in the mother. Cancer Epidemiol Biomarkers Prev 22:835\u2013847. https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-1375","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6606_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/00001648-199911000-00013","volume":"10","author":"KE Innes","year":"1999","unstructured":"Innes KE, Byers TE (1999) Preeclampsia and breast cancer risk. Epidemiology 10:722\u2013732","journal-title":"Epidemiology"},{"key":"6606_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ijc.31364","volume":"143","author":"LB Wright","year":"2018","unstructured":"Wright LB, Schoemaker MJ, Jones ME et al (2018) Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study. Int J Cancer 143:782\u2013792. https:\/\/doi.org\/10.1002\/ijc.31364","journal-title":"Int J Cancer"},{"key":"6606_CR19","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/sj.bjc.6600581","volume":"87","author":"LJ Vatten","year":"2002","unstructured":"Vatten LJ, Romundstad PR, Trichopoulos D, Skj\u00e6rven R (2002) Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 87:971\u2013973. https:\/\/doi.org\/10.1038\/sj.bjc.6600581","journal-title":"Br J Cancer"},{"key":"6606_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13058-017-0930-6","volume":"20","author":"H Yang","year":"2018","unstructured":"Yang H, He W, Eriksson M et al (2018) Inherited factors contribute to an inverse association between preeclampsia and breast cancer. Breast Cancer Res 20:6. https:\/\/doi.org\/10.1186\/s13058-017-0930-6","journal-title":"Breast Cancer Res"},{"key":"6606_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.breast.2015.06.006","volume":"24","author":"NLP Pacheco","year":"2015","unstructured":"Pacheco NLP, Andersen A-MN, Kamper-J\u00f8rgensen M (2015) Preeclampsia and breast cancer: The influence of birth characteristics. The Breast 24:613\u2013617. https:\/\/doi.org\/10.1016\/j.breast.2015.06.006","journal-title":"The Breast"},{"key":"6606_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/bjc.2012.195","volume":"107","author":"S Opdahl","year":"2012","unstructured":"Opdahl S, Romundstad PR, Alsaker MDK, Vatten LJ (2012) Hypertensive diseases in pregnancy and breast cancer risk. Br J Cancer 107:176\u2013182. https:\/\/doi.org\/10.1038\/bjc.2012.195","journal-title":"Br J Cancer"},{"key":"6606_CR23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/ije\/dyv293","volume":"45","author":"M Hajiebrahimi","year":"2016","unstructured":"Hajiebrahimi M, Cnattingius S, Lambe M, Bahmanyar S (2016) Pregnancy history and risk of premenopausal breast cancer-a nested case-control study. Int J Epidemiol 45:816\u2013824. https:\/\/doi.org\/10.1093\/ije\/dyv293","journal-title":"Int J Epidemiol"},{"key":"6606_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14486","volume":"4","author":"C Serrand","year":"2021","unstructured":"Serrand C, Mura T, Fabbro-Peray P et al (2021) Assessment of all-cause cancer incidence among individuals with preeclampsia or eclampsia during first pregnancy. JAMA Netw Open 4:e2114486. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.14486","journal-title":"JAMA Netw Open"},{"key":"6606_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/joim.12747","volume":"283","author":"R Troisi","year":"2018","unstructured":"Troisi R, Bj\u00f8rge T, Gissler M et al (2018) The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. J Intern Med 283:430\u2013445. https:\/\/doi.org\/10.1111\/joim.12747","journal-title":"J Intern Med"},{"key":"6606_CR26","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/ijc.31600","volume":"143","author":"R Troisi","year":"2018","unstructured":"Troisi R, Gulbech Ording A, Grotmol T et al (2018) Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study. Int J Cancer 143:1904\u20131913. https:\/\/doi.org\/10.1002\/ijc.31600","journal-title":"Int J Cancer"},{"key":"6606_CR27","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/bcr2589","volume":"12","author":"H Ma","year":"2010","unstructured":"Ma H, Henderson KD, Sullivan-Halley J et al (2010) Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res 12:R35. https:\/\/doi.org\/10.1186\/bcr2589","journal-title":"Breast Cancer Res"},{"key":"6606_CR28","doi-asserted-by":"publisher","first-page":"63.e1","DOI":"10.1016\/j.ajog.2008.06.057","volume":"200","author":"R Calderon-Margalit","year":"2009","unstructured":"Calderon-Margalit R, Friedlander Y, Yanetz R et al (2009) Preeclampsia and subsequent risk of cancer: update from the Jerusalem Perinatal Study. Am J Obstet Gynecol 200:63.e1\u20135. https:\/\/doi.org\/10.1016\/j.ajog.2008.06.057","journal-title":"Am J Obstet Gynecol"},{"key":"6606_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168469","volume":"11","author":"EJ Kang","year":"2016","unstructured":"Kang EJ, Seo JH, Kim LY et al (2016) Pregnancy-associated risk factors of postpartum breast cancer in korea: a nationwide health insurance database study. PLoS ONE 11:e0168469. https:\/\/doi.org\/10.1371\/journal.pone.0168469","journal-title":"PLoS ONE"},{"key":"6606_CR30","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1080\/14767058.2017.1342806","volume":"31","author":"M Sun","year":"2018","unstructured":"Sun M, Fan Y, Hou Y, Fan Y (2018) Preeclampsia and maternal risk of breast cancer: a meta-analysis of cohort studies. J Matern Fetal Neonatal Med 31:2484\u20132491. https:\/\/doi.org\/10.1080\/14767058.2017.1342806","journal-title":"J Matern Fetal Neonatal Med"},{"key":"6606_CR31","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/bmj.38032.820451.7C","volume":"328","author":"O Paltiel","year":"2004","unstructured":"Paltiel O, Friedlander Y, Tiram E et al (2004) Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort. BMJ 328:919. https:\/\/doi.org\/10.1136\/bmj.38032.820451.7C","journal-title":"BMJ"},{"key":"6606_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/10641955.2016.1258411","volume":"36","author":"L-T Lin","year":"2017","unstructured":"Lin L-T, Hu L-Y, Tang P-L et al (2017) Do racial differences exist in the association between pregnancy-induced hypertension and breast cancer risk? Hypertens Pregnancy 36:138\u2013144. https:\/\/doi.org\/10.1080\/10641955.2016.1258411","journal-title":"Hypertens Pregnancy"},{"key":"6606_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/10641955.2015.1071838","volume":"34","author":"A Walfisch","year":"2015","unstructured":"Walfisch A, Kessous R, Davidson E et al (2015) Pre-eclampsia and Future Female Malignancy. Hypertens Pregnancy 34:456\u2013463. https:\/\/doi.org\/10.3109\/10641955.2015.1071838","journal-title":"Hypertens Pregnancy"},{"key":"6606_CR34","first-page":"56","volume":"50","author":"L Rosenberg","year":"1972","unstructured":"Rosenberg L, Adams-Campbell L (1972) The Black Women\u2019s health study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc 50:56\u201358","journal-title":"J Am Med Womens Assoc"},{"key":"6606_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113715","volume":"9","author":"TER Gillon","year":"2014","unstructured":"Gillon TER, Pels A, von Dadelszen P et al (2014) Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS ONE 9:e113715. https:\/\/doi.org\/10.1371\/journal.pone.0113715","journal-title":"PLoS ONE"},{"key":"6606_CR36","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","volume":"335","author":"L Bellamy","year":"2007","unstructured":"Bellamy L, Casas J-P, Hingorani AD, Williams DJ (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335:974. https:\/\/doi.org\/10.1136\/bmj.39335.385301.BE","journal-title":"BMJ"},{"key":"6606_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/aogs.13296","volume":"97","author":"M Kamper-J\u00f8rgensen","year":"2018","unstructured":"Kamper-J\u00f8rgensen M, Gammill HS, Nelson JL (2018) Preeclampsia and scleroderma: a prospective nation-wide analysis. Acta Obstet Gynecol Scand 97:587\u2013590. https:\/\/doi.org\/10.1111\/aogs.13296","journal-title":"Acta Obstet Gynecol Scand"},{"key":"6606_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11892-015-0579-4","volume":"15","author":"TL Weissgerber","year":"2015","unstructured":"Weissgerber TL, Mudd LM (2015) Preeclampsia and Diabetes. Curr Diab Rep 15:579. https:\/\/doi.org\/10.1007\/s11892-015-0579-4","journal-title":"Curr Diab Rep"},{"key":"6606_CR39","unstructured":"S Ananth Karumanchi, Kee-Hak Kim, Phyllis August Preeclampsia: Pathogenesis. In: UpToDate. https:\/\/www.uptodate.com\/contents\/preeclampsia-pathogenesis. Accessed 22 Jul 2020"},{"key":"6606_CR40","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.2147\/DDDT.S304316","volume":"15","author":"C Shu","year":"2021","unstructured":"Shu C, Han S, Xu P et al (2021) Estrogen and preeclampsia: potential of estrogens as therapeutic agents in preeclampsia. DDDT 15:2543\u20132550. https:\/\/doi.org\/10.2147\/DDDT.S304316","journal-title":"DDDT"},{"key":"6606_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12958-020-0569-5","volume":"18","author":"K-C Lan","year":"2020","unstructured":"Lan K-C, Lai Y-J, Cheng H-H et al (2020) Levels of sex steroid hormones and their receptors in women with preeclampsia. Reprod Biol Endocrinol 18:12. https:\/\/doi.org\/10.1186\/s12958-020-0569-5","journal-title":"Reprod Biol Endocrinol"},{"key":"6606_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1161\/HYPERTENSIONAHA.111.201624","volume":"61","author":"SO Jobe","year":"2013","unstructured":"Jobe SO, Tyler CT, Magness RR (2013) Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia implications for vascular dysfunction. Hypertension 61:480\u2013487. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.201624","journal-title":"Hypertension"},{"key":"6606_CR43","doi-asserted-by":"publisher","first-page":"477.e1","DOI":"10.1016\/j.ajog.2010.06.011","volume":"203","author":"A Hertig","year":"2010","unstructured":"Hertig A, Liere P, Chabbert-Buffet N et al (2010) Steroid profiling in preeclamptic women: evidence for aromatase deficiency. Am J Obstet Gynecol 203:477.e1-477.e9. https:\/\/doi.org\/10.1016\/j.ajog.2010.06.011","journal-title":"Am J Obstet Gynecol"},{"key":"6606_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.preghy.2017.12.003","volume":"11","author":"J Wan","year":"2018","unstructured":"Wan J, Hu Z, Zeng K et al (2018) The reduction in circulating levels of estrogen and progesterone in women with preeclampsia. Pregnancy Hypertension 11:18\u201325. https:\/\/doi.org\/10.1016\/j.preghy.2017.12.003","journal-title":"Pregnancy Hypertension"},{"key":"6606_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1210\/er.2016-1065","volume":"38","author":"N Berkane","year":"2017","unstructured":"Berkane N, Liere P, Oudinet J-P et al (2017) From Pregnancy to Preeclampsia: A Key Role for Estrogens. Endocr Rev 38:123\u2013144. https:\/\/doi.org\/10.1210\/er.2016-1065","journal-title":"Endocr Rev"},{"key":"6606_CR46","first-page":"1004","volume":"82","author":"A H\u00fcbinette","year":"2003","unstructured":"H\u00fcbinette A, Lichtenstein P, Brismar K et al (2003) Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand 82:1004\u20131009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"6606_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/sj.bjc.6602374","volume":"92","author":"H Bando","year":"2005","unstructured":"Bando H, Weich HA, Brokelmann M et al (2005) Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer. Br J Cancer 92:553\u2013561. https:\/\/doi.org\/10.1038\/sj.bjc.6602374","journal-title":"Br J Cancer"},{"key":"6606_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/123717","volume":"2011","author":"M Furuya","year":"2011","unstructured":"Furuya M, Kurasawa K, Nagahama K et al (2011) Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia. J Pregnancy 2011:1\u201310. https:\/\/doi.org\/10.1155\/2011\/123717","journal-title":"J Pregnancy"},{"key":"6606_CR49","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/CS20150702","volume":"130","author":"AC Harmon","year":"2016","unstructured":"Harmon AC, Cornelius DC, Amaral LM et al (2016) The role of inflammation in the pathology of preeclampsia. Clin Sci 130:409\u2013419. https:\/\/doi.org\/10.1042\/CS20150702","journal-title":"Clin Sci"},{"key":"6606_CR50","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0140-6736(99)80010-5","volume":"354","author":"LC Chappell","year":"1999","unstructured":"Chappell LC, Seed PT, Briley AL et al (1999) Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. The Lancet 354:810\u2013816. https:\/\/doi.org\/10.1016\/S0140-6736(99)80010-5","journal-title":"The Lancet"},{"key":"6606_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","volume":"357","author":"J Roberts","year":"2001","unstructured":"Roberts J, Cooper D (2001) Pathogenesis and genetics of pre-eclampsia. The Lancet 357:53\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(00)03577-7","journal-title":"The Lancet"},{"key":"6606_CR52","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/0002-9378(89)90778-3","volume":"161","author":"CA Hubel","year":"1989","unstructured":"Hubel CA, Roberts JM, Taylor RN et al (1989) Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol 161:1025\u20131034. https:\/\/doi.org\/10.1016\/0002-9378(89)90778-3","journal-title":"Am J Obstet Gynecol"},{"key":"6606_CR53","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/jwh.2016.5973","volume":"26","author":"JD Lee","year":"2017","unstructured":"Lee JD, Cai Q, Shu XO, Nechuta SJ (2017) The role of biomarkers of oxidative stress in breast cancer risk and prognosis: a systematic review of the epidemiologic literature. Journal of Women\u2019s Health 26:467\u2013482. https:\/\/doi.org\/10.1089\/jwh.2016.5973","journal-title":"Journal of Women\u2019s Health"},{"key":"6606_CR54","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1126\/science.1111726","volume":"308","author":"CW Redman","year":"2005","unstructured":"Redman CW (2005) Latest advances in understanding preeclampsia. Science 308:1592\u20131594. https:\/\/doi.org\/10.1126\/science.1111726","journal-title":"Science"},{"key":"6606_CR55","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1600-0897.2012.01158.x","volume":"68","author":"R Boij","year":"2012","unstructured":"Boij R, Svensson J, Nilsson-Ekdahl K et al (2012) Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia. Am J Reprod Immunol 68:258\u2013270. https:\/\/doi.org\/10.1111\/j.1600-0897.2012.01158.x","journal-title":"Am J Reprod Immunol"},{"key":"6606_CR56","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/00001648-199811000-00014","volume":"9","author":"R Troisi","year":"1998","unstructured":"Troisi R, Weiss HA, Hoover RN et al (1998) Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9:641\u2013647","journal-title":"Epidemiology"},{"key":"6606_CR57","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/sj.bjc.6603921","volume":"97","author":"R Troisi","year":"2007","unstructured":"Troisi R, Innes KE, Roberts JM, Hoover RN (2007) Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role? Br J Cancer 97:688\u2013690. https:\/\/doi.org\/10.1038\/sj.bjc.6603921","journal-title":"Br J Cancer"},{"key":"6606_CR58","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/aje\/kwk105","volume":"165","author":"MB Terry","year":"2007","unstructured":"Terry MB, Perrin M, Salafia CM et al (2007) Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol 165:1007\u20131014. https:\/\/doi.org\/10.1093\/aje\/kwk105","journal-title":"Am J Epidemiol"},{"key":"6606_CR59","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.ajog.2007.09.038","volume":"198","author":"CL Diehl","year":"2008","unstructured":"Diehl CL, Brost BC, Hogan MC et al (2008) Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. Am J Obstet Gynecol 198:e11\u2013e13. https:\/\/doi.org\/10.1016\/j.ajog.2007.09.038","journal-title":"Am J Obstet Gynecol"},{"key":"6606_CR60","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s10995-014-1487-y","volume":"18","author":"P Dietz","year":"2014","unstructured":"Dietz P, Bombard J, Mulready-Ward C et al (2014) Validation of self-reported maternal and infant health indicators in the pregnancy risk assessment monitoring system. Matern Child Health J 18:2489\u20132498. https:\/\/doi.org\/10.1007\/s10995-014-1487-y","journal-title":"Matern Child Health J"},{"key":"6606_CR61","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jclinepi.2009.10.010","volume":"63","author":"M Coolman","year":"2010","unstructured":"Coolman M, de Groot CJM, Jaddoe VW et al (2010) Medical record validation of maternally reported history of preeclampsia. J Clin Epidemiol 63:932\u2013937. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.10.010","journal-title":"J Clin Epidemiol"},{"key":"6606_CR62","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1089\/jwh.2014.4953","volume":"24","author":"EB Carter","year":"2015","unstructured":"Carter EB, Stuart JJ, Farland LV et al (2015) Pregnancy complications as markers for subsequent maternal cardiovascular disease: validation of a maternal recall questionnaire. Journal of Women\u2019s Health 24:702\u2013712. https:\/\/doi.org\/10.1089\/jwh.2014.4953","journal-title":"Journal of Women\u2019s Health"},{"key":"6606_CR63","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1067\/mob.2001.112905","volume":"184","author":"JR Barton","year":"2001","unstructured":"Barton JR, O\u2019Brien JM, Bergauer NK et al (2001) Mild gestational hypertension remote from term: Progression and outcome. Am J Obstet Gynecol 184:979\u2013983. https:\/\/doi.org\/10.1067\/mob.2001.112905","journal-title":"Am J Obstet Gynecol"},{"key":"6606_CR64","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.116.07862","volume":"68","author":"LA Magee","year":"2016","unstructured":"Magee LA, von Dadelszen P, Singer J et al (2016) The CHIPS randomized controlled trial (Control of Hypertension in Pregnancy Study): is severe hypertension just an elevated blood Pressure? Hypertension 68:1153\u20131159. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.07862","journal-title":"Hypertension"},{"key":"6606_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC et al (2018) Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 72:24\u201343. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10803","journal-title":"Hypertension"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06606-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T15:07:39Z","timestamp":1654355259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06606-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["6606"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06606-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"15 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Karen M. Freund receives support from the American Cancer Society (# CRP-17\u2013112-06-COUN) and the Susan G. Komen Foundation (GTDR15333918). She received a $1000 honorarium from the National Minority Quality Forum to support the work of the National Minority Quality Forum in developing a framework on addressing cancer health disparities in 2019, which was prior to initiation of the current research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All study procedures received approval by the Boston University Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}